Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Business Channel.
Press releases published on April 28, 2025

Volatus annonce un financement de 2 000 000 $
Interdiction de diffusion aux agences de presse américaines et de diffusion aux États-Unis. TORONTO, 28 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») a le plaisir d' …

AppLovin Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 5, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AppLovin Corporation ("AppLovin" or the "Company") (NASDAQ: APP) investors of a class …

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

e.l.f. Beauty, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 5, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises e.l.f. Beauty, Inc. ("e.l.f. Beauty" or the "Company") (NYSE: ELF) investors of a class …

ROSEN, A LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) …

GROUNDBREAKING NON-INVASIVE THERAPY TREATING FIRST RESPONDERS AND VETERANS, SCORES BIG WITH PROFESSIONAL ATHLETES
VECTTOR™ Technology, a groundbreaking non-invasive therapy designed to treat chronic pain and neurological disorders, is scoring big with professional athletes. WIMBERLEY, TX, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- VECTTOR™ Technology, a …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Storytime Bookshop Launches $15,000 Crowdfunding Campaign to Expand Access to Books and Creative Literacy Programs
Kennewick, WA, April 28, 2025 (GLOBE NEWSWIRE) -- Storytime Bookshop, a vibrant children’s bookstore located in downtown Kennewick, has launched a $15,000 crowdfunding campaign through NuMarket, a community-driven platform designed to help small businesses …

Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
- Oral presentation to include preclinical data supporting the clinical advancement of ABO-101 for the treatment of primary hyperoxaluria type 1 - Four poster presentations collectively demonstrate advancement of company’s differentiated CNS gene editing …

Manhattan Associates, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 28, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Manhattan Associates, Inc. ("Manhattan Associates" or the "Company") (NASDAQ: MANH) …

BLZE Announcement: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that …

Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the first quarter ended March 31, 2025 on Monday, May 12, 2025 before the market opens. The company will hold …

Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annual …

Trident Filed 2024 Annual Report on Form 20-F
SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today …

RBB Bancorp Reports First Quarter 2025 Earnings
LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the “Bank”) and RBB Asset Management Company (“RAM”), collectively referred to herein as the “Company,” announced financial results for the …

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate …

Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene therapy programs in Gaucher disease, GBA1 Parkinson’s disease and adrenomyeloneuropathy in oral and poster presentations at the American …

Macerich Declares the Quarterly Dividend on Its Common Shares
SANTA MONICA, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on June 17, 2025, to stockholders of record …

Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, today announced that Co-Founder and Chief Scientific Officer, Dr. Victor Hernandez, …

Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the upcoming 28th Annual Meeting of the American Society of Gene …